THX Pharma Société Anonyme (FRA:3VG)
Germany flag Germany · Delayed Price · Currency is EUR
1.695
+0.185 (12.25%)
At close: Nov 27, 2025

FRA:3VG Statistics

Total Valuation

FRA:3VG has a market cap or net worth of EUR 23.59 million. The enterprise value is 24.35 million.

Market Cap23.59M
Enterprise Value 24.35M

Important Dates

The next estimated earnings date is Wednesday, December 24, 2025.

Earnings Date Dec 24, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 13.80M
Shares Outstanding n/a
Shares Change (YoY) +21.67%
Shares Change (QoQ) +1.35%
Owned by Insiders (%) 4.81%
Owned by Institutions (%) 7.06%
Float 13.13M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 26.93
PB Ratio -12.49
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -8.29
EV / Sales 27.79
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -27.29

Financial Position

The company has a current ratio of 0.86

Current Ratio 0.86
Quick Ratio 0.84
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -3.23
Interest Coverage -38.45

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -50.49%
Return on Invested Capital (ROIC) -113.12%
Return on Capital Employed (ROCE) -502.66%
Revenue Per Employee 87,613
Profits Per Employee -293,787
Employee Count10
Asset Turnover 0.20
Inventory Turnover n/a

Taxes

Income Tax -557,579
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +287.87% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +287.87%
50-Day Moving Average 2.16
200-Day Moving Average 1.41
Relative Strength Index (RSI) 39.98
Average Volume (20 Days) 754

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:3VG had revenue of EUR 876,129 and -2.94 million in losses. Loss per share was -0.31.

Revenue876,129
Gross Profit -1.47M
Operating Income -3.55M
Pretax Income -3.50M
Net Income -2.94M
EBITDA -3.45M
EBIT -3.55M
Loss Per Share -0.31
Full Income Statement

Balance Sheet

The company has 2.12 million in cash and 2.88 million in debt, giving a net cash position of -757,142.

Cash & Cash Equivalents 2.12M
Total Debt 2.88M
Net Cash -757,142
Net Cash Per Share n/a
Equity (Book Value) -1.89M
Book Value Per Share -0.20
Working Capital -539,563
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -889,810 and capital expenditures -2,507, giving a free cash flow of -892,317.

Operating Cash Flow -889,810
Capital Expenditures -2,507
Free Cash Flow -892,317
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin -167.83%
Operating Margin -405.42%
Pretax Margin -398.96%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

FRA:3VG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.67%
Shareholder Yield -21.67%
Earnings Yield -12.45%
FCF Yield -3.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:3VG has an Altman Z-Score of -3.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.13
Piotroski F-Score 2